112 related articles for article (PubMed ID: 29920670)
1. Urokinase-plasminogen activator protects periodontal ligament fibroblast from oxidative induced-apoptosis and DNA damage.
Ahmad Akhoundi MS; Rokn A; Bagheri R; Momeni N; Hodjat M
J Periodontal Res; 2018 Oct; 53(5):861-869. PubMed ID: 29920670
[TBL] [Abstract][Full Text] [Related]
2. Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction.
Hohensinner PJ; Takacs N; Kaun C; Thaler B; Krychtiuk KA; Pfaffenberger S; Aliabadi A; Zuckermann A; Huber K; Wojta J
Apoptosis; 2017 Aug; 22(8):1048-1055. PubMed ID: 28643198
[TBL] [Abstract][Full Text] [Related]
3. Effects of platelet-derived growth factor isoforms on plasminogen activation by periodontal ligament and gingival fibroblasts.
Agis H; Bauer M; Knebl G; Watzek G; Gruber R
J Periodontal Res; 2008 Jun; 43(3):334-42. PubMed ID: 18447857
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen sulfide induces apoptosis in human periodontium cells.
Zhang JH; Dong Z; Chu L
J Periodontal Res; 2010 Feb; 45(1):71-8. PubMed ID: 19602114
[TBL] [Abstract][Full Text] [Related]
5. A novel molecule, SLURP-1, enhances the survival of periodontal ligament fibroblasts.
Phan TC; Ooi J; Goonewardene MS
J Periodontal Res; 2010 Jun; 45(3):331-6. PubMed ID: 20337899
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin induces apoptosis and disruption of the actin cytoskeleton in human dental pulp cells and periodontal ligament fibroblasts.
Saewong S; Thammasitboon K; Wattanaroonwong N
Arch Oral Biol; 2013 Aug; 58(8):964-74. PubMed ID: 23561831
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activation by fibroblasts from periodontal ligament and gingiva is not directly affected by chemokines in vitro.
Sarajlic J; Agis H; Kandler B; Watzek G; Gruber R
Arch Oral Biol; 2007 Jul; 52(7):663-8. PubMed ID: 17296163
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
9. Effect of urokinase type plasminogen activator on
Roldán-Olarte M; Maillo V; Sánchez-Calabuig MJ; Beltrán-Breña P; Rizos D; Gutiérrez-Adán A
Reproduction; 2017 Sep; 154(3):231-240. PubMed ID: 28667127
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export.
Khateeb J; Kiyan Y; Aviram M; Tkachuk S; Dumler I; Fuhrman B
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):449-58. PubMed ID: 22155455
[TBL] [Abstract][Full Text] [Related]
11. Urokinase induces survival or pro-apoptotic signals in human mesangial cells depending on the apoptotic stimulus.
Tkachuk N; Kiyan J; Tkachuk S; Kiyan R; Shushakova N; Haller H; Dumler I
Biochem J; 2008 Oct; 415(2):265-73. PubMed ID: 18564064
[TBL] [Abstract][Full Text] [Related]
12. Effect of tension-force on plasminogen activator activity from human periodontal ligament cells.
Yamaguchi M; Shimizu N; Ozawa Y; Saito K; Miura S; Takiguchi H; Iwasawa T; Abiko Y
J Periodontal Res; 1997 Apr; 32(3):308-14. PubMed ID: 9138197
[TBL] [Abstract][Full Text] [Related]
13. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
14. Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activity.
Chen YX; O'Brien ER
Can J Physiol Pharmacol; 2003 Jul; 81(7):730-9. PubMed ID: 12897821
[TBL] [Abstract][Full Text] [Related]
15. Increase of urokinase-type plasminogen activator receptor expression in human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide.
Ogura N; Nagura H; Abiko Y
J Periodontol; 1999 Apr; 70(4):402-8. PubMed ID: 10328652
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
Jankun J; Skrzypczak-Jankun E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
[TBL] [Abstract][Full Text] [Related]
17. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
Stæhr M; Buhl KB; Andersen RF; Svenningsen P; Nielsen F; Hinrichs GR; Bistrup C; Jensen BL
Am J Physiol Renal Physiol; 2015 Aug; 309(3):F235-41. PubMed ID: 25972510
[TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
[TBL] [Abstract][Full Text] [Related]
19. L-mimosine and dimethyloxaloylglycine decrease plasminogen activation in periodontal fibroblasts.
Wehner C; Gruber R; Agis H
J Periodontol; 2014 Apr; 85(4):627-35. PubMed ID: 23826644
[TBL] [Abstract][Full Text] [Related]
20. The expression of plasminogen activator system in a rat model of periodontal wound healing.
Xiao Y; Li H; Bunn C; Bartold PM
J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]